ARCA biopharma, Inc. (Nasdaq: ABIO) reports that it is planning to expand the development of Gencaro, its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE